<SEC-DOCUMENT>0001193125-18-226085-index.html : 20180725
<SEC-HEADER>0001193125-18-226085.hdr.sgml : 20180725
<ACCEPTANCE-DATETIME>20180725172733
ACCESSION NUMBER:		0001193125-18-226085
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180725
DATE AS OF CHANGE:		20180725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EyePoint Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001314102
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				262774444
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-226341
		FILM NUMBER:		18969471

	BUSINESS ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-926-5000

	MAIL ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pSivida Corp.
		DATE OF NAME CHANGE:	20080619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pSivida LTD
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d576002ds3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: d576002ds3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d576002dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d576002dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>d576002dex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
Document 3 - file: d576002dex211.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d576002dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: d576002dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g576002g0725075924972.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g576002g0725075924972.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g576002g0725080823339.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g576002g0725080823339.jpg

</DOCUMENT>
</SEC-DOCUMENT>